GPRC5A and cancer: Initial research suggests that at least some of the GPCRs Paul et al. discovered are active in cancer cells (for example, GPR161 in breast cancer [390] and GPRC5A in pancreatic cancer [391]) and the micro-environment (e.g., GPR68 [389]).